Update on GDUFA Science and Research

Director of the Office of Research and Standards Robert Lionberger, Ph.D., in CDER’s Office of Generic Drugs discusses state and scale of GDUFA topics and keys to success for complex generics.

_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Phone - [phone] I [phone]